Cytokines Interact with the Blood-Brain Barrier

Blood-Brain Barriers: From Ontogeny to Artificial Interfaces

Volumn 1, Issue , 2007, Pages 247-264

  Pan, Weihong ^a   Xiang, Shulin ^a   Tu, Hong ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Brain vessels; Cytokines cross BBB; Cytokines interact with blood brain barrier; Cytokines known effects on endothelial cells; Cytokines permeate BBB; Enzymatic control; Hormonal control; Mechanisms; Neurodegenerative disorders; Regulation; Simple diffusion; Specific transport systems; Stroke; Vasculopathy

Indexed keywords

BLOOD-BRAIN BARRIER; CYTOKINES;

EID: 84890973537     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527611225.ch11     Document Type: Chapter

References (86)

1. Aoki, T., Sumii, T., Mori, T., Wang, X., Lo, E. H. 2002, Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury, Stroke 33, 2711-2717.
2. Argiles, J. M., Busquets, S., Lopez-Soriano, F. J. 2003, Cytokines in the pathogenesis of cancer cachexia, Curr. Opin. Clin. Nutr. Metab. Care 6, 401-406.
3. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M.A., Fini, M. E., Lo, E.H. 2001, Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia, J. Neurosci. 21, 7724-7732.
4. Azari, M.F., Galle, A., Lopes, E. C., Kurek, J., Cheema, S. S. 2001, Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis, Brain Res. 922, 144-147.
5. G93A G1H mouse model of familial amyotrophic lateral sclerosis, Brain Res. 982, 92-97.
6. Balabanov, R., Dore-Duffy, P. 1998, Role of the CNS microvascular pericyte in the blood-brain barrier, J. Neurosci. Res. 53, 637-644.
7. Banks, W. A., Kastin, A. J. 1996, Reversible association of the cytokines MIP-1a and MIP-1b with the endothelia of the blood-brain barrier, Neurosci. Lett. 205, 202-206.
8. Banks, W. A., Kastin, A. J., Durham, D.A. 1989, Bidirectional transport of interleukin-1 alpha across the blood-brain barrier, Brain Res. Bull. 23, 433-437.
9. Banks, W. A., Kastin, A. J., Gutierrez, E.G. 1993, Interleukin-1α in blood has direct access to cortical brain cells, Neurosci. Lett. 163, 41-44.
10. Banks, W. A., Kastin, A. J., Gutierrez, E.G. 1994, Penetration of interleukin-6 across the murine blood-brain barrier, Neurosci. Lett. 179, 53-56.
11. Banks, W. A., Moinuddin, A., Morley, J. E. 2001, Regional transport of TNF-α across the blood-brain barrier in young ICR and young and aged SAMP8 mice, Neurobiol. Aging 22, 671-676.
12. Banks, W. A., Ortiz, L., Plotkin, S. R., Kastin, A. J. 1991, Human interleukin (IL)1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism, J. Pharmacol. Exp. Ther. 259, 988-996.
13. Banks, W. A., Plotkin, S. R., Kastin, A. J. 1995, Permeability of the blood-brain barrier to soluble cytokine receptors Neuroimmunomodulation 2: 161-165.
14. Barten, D.M., Ruddle, N.H. 1994, Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis, J. Neuroimmunol. 51, 123-133.
15. Berti, R., Williams, A. J., Moffett, J. R., Hale, S. L., Velarde, L. C., Elliott, P. J., Yao, C., Dave, J. R., Tortella, F. C. 2002, Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury, J. Cereb. Blood Flow Metab. 22, 1068-1079.
16. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., DeClercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., Volterra, A. 2001, CXCR4-activated astrocyte glutamate release via TNF-α: amplification by microglia triggers neurotoxicity, Nat. Neurosci. 4, 702-710.
17. Bhattacharjee, A. K., Kondoh, T., Ikeda, M., Kohmura, E. 2002, MMP-9 and EBA immunoreactivity after papaverine mediated opening of the blood-brain barrier, NeuroReport 13, 2217-2221.
18. Botchkina, G. I., Meistrell, M.E. I., Botchkina, I. L., Tracey, K. J. 1997, Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia, Mol. Med. 3, 765-781.
19. Camussi, G., Turello, E., Bussolino, F., Baglioni, C. 1991, Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells, Int. Arch. Allergy Appl. Immunol. 96, 84-91.
20. Conner, S. D., Schmid, S. L. 2003, Regulated portals of entry into the cell, Nature 422, 37-44.
21. mapk/erk2 induces changes in its subcellular localization, J. Biol. Chem. 274, 32975-32987.
22. Deguchi, Y., Okutsu, H., Okura, T., Yamada, S., Kimura, R., Yuge, T., Furukawa, A., Morimoto, K., Tachikawa, M., Ohtsuki, S., Hosoya, K., Terasaki, T. 2002, Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan, J. Neurochem. 83, 381-389.
23. Dobbie, M.S., Hurst, R. D., Klein, N. J., Surtees, R. A. 1999, Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumour necrosis factor-alpha in an in vitro model of the blood-brain barrier, Brain Res. 830, 330-336.
24. Dore-Duffy, P., Washington, R. A., Balabanov, R. 1994, Cytokine-mediated activation of cultured CNS microvessels: a system for examining antigenic modulation of CNS endothelial cells, and evidence for long-term expression of the adhesion protein E-selectin, J. Cereb. Blood Flow Metab. 14, 837-844.
25. Dvorak, H.F., Brown, L. F., Detmar, M., Dvorak, A.M. 1995, Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability, and angiogenesis, Am. J. Pathol. 146, 1029-1039.
26. Elliott, J. L. 2001, Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis, Mol. Brain Res. 95, 172-178.
27. Estrada, C., Gomez, C., Martin, C. 1995, Effects of TNFα on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture, J. Cereb. Blood Flow Metab. 15, 920-928.
28. Franzén, B., Duvefelt, K., Jonsson, C., Engelhardt, B., Ottervald, J., Wickman, M., Yang, Y., Schuppe-Koistinen, I. 2003, Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-α, Mol. Brain Res. 115, 130-146.
29. Gary, D. S., Bruce-Keller, A. J., Kindy, M. S., Mattson, M.P. 1998, Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor, J. Cereb. Blood Flow Metab. 18, 1283-1287.
30. Giess, R., Beck, M., Goetz, R., Nitsch, R. M., Toyka, K.V., Sendtner, M. 2000, Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis, Neurology 54, 1003-1005.
31. Gutierrez, E. G., Banks, W. A., Kastin, A. J. 1993, Murine tumor necrosis factor alpha is transported from blood to brain in the mouse, J. Neuroimmunol. 47, 169-176.
32. Hallenbeck, J.M. 2002, The many faces of tumor necrosis factor in stroke, Nat. Med. 8, 1363-1368.
33. Harkness, K. A., Sussman, J. D., Davies-Jones, G. A., Greenwood, J., Woodroofe, M.N. 2003, Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells, J. Neuroimmunol. 142, 1-9.
34. Hensley, K., Fedynyshyn, J., Ferrell, S., Floyd, R. A., Gordon, B., Grammas, P., Hamdheydari, L., Mhatre, M., Mou, S., Pye, Q.N., Stewart, C., West, M., West, S., Williamson, K. S. 2003, Message and protein-level elevation of tumor necrosis factor α (TNFa) and TNFa-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis, Neurobiology 14, 74-80.
35. Hensley, K., Floyd, R. A., Gordon, B., Mou, S., Pye, Q.N., Stewart, C., West, M., Williamson, K. 2002, Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G94A-SOD1 mouse model of amyotrophic lateral sclerosis, J. Neurochem. 82, 365-374.
36. Hicke, L., Dunn, R. 2003, Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins, Annu. Rev. Cell Dev. Biol. 19, 141-172.
37. Jones, S. J., Ledgerwood, E. C., Prins, J. B., Galbraith, J., Johnson, D.R., Pober, J. S., Bradley, J.R. 1999, TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1, J. Immunol. 162, 1042-1048.
38. Kastin, A. J., Akerstrom, V., Pan, W. 2003, Interleukin-10 as a CNS therapeutic:the obstacle of the blood-brain/blood-spinal cord barrier, Mol. Brain Res. 114, 168-171.
39. Kurek, J. B., Radford, A. J., Crump, D.E., Bower, J. J., Feeney, S. J., Austin, L., Byrne, E. 1998, LIF (AM424), a promising growth factor for the treatment of ALS, J. Neurol. Sci. 160, S106-S113.
40. Lai, E. C., Felice, K. J., Festoff, B.W., Gawel, M.J., Gelinas, D.F., Murphy, M.F., Natter, H. M., Norris, F. H., Rudnicki, S. A. 1997, Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I study group, Neurology 49, 1621-1630.
41. Leonardi, A., Abbruzzese, G., Arata, L., Cocito, L., Vische, M. 1984, Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis, J. Neurol. 231, 75-78.
42. Leonardi, A., Abbruzzese, G., Arata, L., Cocito, L., Vische, M. 2004, Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis, J. Neurol. 231, 75-78.
43. Liu, X., Yao, D.L., Webster, H. 1995, Insulin-like growth factor 1 treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis, Mult. Scler. 1, 2-9.
44. Male, D., Rahman, J., Pryce, G., Tamatani, T., Miyasaka, M. 1994, Lymphocyte migration into the CNS modelled in vitro: roles of LFA-1, ICAM-1 and VLA-4, Immunology 81, 366-372.
45. Masada, T., Hua, Y., Xi, G., Ennis, S. R., Keep, R. F. 2001, Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat, J. Cereb. Blood Flow Metab. 21, 22-33.
46. McCarron, R. M., Wang, L., Racke, M.K., McFarlin, D.E., Spatz, M. 1993, Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells, J. Neuroimmunol. 43, 23-30.
47. McLay, R. N., Kastin, A. J., Zadina, J. E. 2000, Passage of interleukin-1-beta across the blood-brain barrier is reduced in aged mice: a possible mechanism for diminished fever in aging, Neuroimmunomodulation 8, 148-153.
48. Meistrell, M.E. I., Botchkina, G. I., Wang, H., Di Santo, E., Cockroft, K. M., Vishnubhakat, J. M., Ghezzi, P., Traces, K. J. 1997, Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia, Shock 8, 341-348.
49. Menter, D. G., Herrmann, J. L., Nicolson, G. L. 1995, The role of trophic factors and autocrine/paracrine growth factors in brain metastasis, Clin. Exp. Metastasis 13, 67-88.
50. Nawashiro, H., Martin, D., Hallenbeck, J.M. 1997, Inhibition of tumor necrosis factor and amelioration of brain infarction in mice, J. Cereb. Blood Flow Metab. 17, 229-232.
51. Nawashiro, H., Tasaki, K., Ruetzler, C. A., Hallenbeck, J.M. 1997, TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice, J. Cereb. Blood Flow Metab. 17, 483-490.
52. Pan, W., Akerstrom, V., Zhang, J., Pejovic, V., Kastin, A. J. 2004, Modulation of feeding-related peptide/protein signals by the blood-brain barrier, J. Neurochem. 90, 455-461.
53. Pan, W., Banks, W. A., Kastin, A. J. 1997, Permeability of the blood-brain and blood-spinal cord barriers to interferons, J. Neuroimmunol. 76, 105-111.
54. Pan, W., Banks, W. A., Kastin, A. J. 1998, Permeability of the blood-brain barrier to neurotrophins, Brain Res. 788, 87-94.
55. Pan, W., Banks, W. A., Kennedy, M. K., Gutierrez, E. G., Kastin, A. J. 1996, Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α, Am. J. Physiol. 271, E636-E642.
56. Pan, W., Cain, C., Tu, H., Yu, Y., Zhang, L., Kastin, A. J. 2005, Receptormediated transport of LIF across blood-spinal cord barrier is upregulated after SCI (submitted).
57. Pan, W., Cornelissen, G., Halberg, F., Kastin, A J. 2002, Selected contribution:circadian rhythm of tumor necrosis factor-alpha uptake into mouse spinal cord, J. Appl. Physiol. 92, 1357-1362.
58. Pan, W., Ding, Y., Zhang, J., Kastin, A. J. 2005, Stroke increases transport of TNFα across the blood-brain barrier that is partially mediated by the receptors (submitted).
59. Pan, W., Csernus, B., Kastin, A. J. 2003, Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier, J. Mol. Neurosci. 21, 173-184.
60. Pan, W., Kastin, A. J. 1999, Entry of EGF into brain is rapid and saturable, Peptides 20, 1091-1098.
61. Pan, W., Kastin, A. J. 2000, Interactions of IGF-1 with the blood-brain barrier in vivo and in situ, Neuroendocrinology 72, 171-178.
62. Pan, W., Kastin, A. J. 2001a, Changing the chemokine gradient: CINC1 crosses the blood-brain barrier, J. Neuroimmunol. 115, 64-70.
63. Pan, W., Kastin, A. J. 2001b, Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system, Life Sci. 68, 2705-2714.
64. Pan, W., Kastin, A. J. 2001c, Increase in TNFα transport after SCI is specific for time, region, and type of lesion, Exp. Neurol. 170, 357-363.
65. Pan, W., Kastin, A. J. 2002, TNFα transport across the blood-brain barrier is abolished in receptor knockout mice, Exp. Neurol. 174, 193-200.
66. Pan, W., Kastin, A. J. 2003, Interactions of cytokines with the blood-brain barrier:implications for feeding, Curr. Pharm. Des. 9, 827-831.
67. Pan, W., Kastin, A. J., Bell, R. L., Olson, R. D. 1999, Upregulation of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury, J. Neurosci. 19, 3649-3655.
68. Pan, W., Kastin, A. J., Brennan, J.M. 2000, Saturable entry of leukemia inhibitory factor from blood to the central nervous system, J. Neuroimmunol. 106, 172-180.
69. Pan, W., Kastin, A. J., Maness, L. M., Brennan, J.M. 1999, Saturable entry of ciliary neurotrophic factor into brain, Neurosci. Lett. 263, 69-71.
70. Pan, W., Vallance, K., Kastin, A. J. 1999, TGFα and the blood-brain barrier:accumulation in cerebral vasculature, Exp. Neurol. 160, 454-459.
71. Pan, W., Yu, Y., Nyberg, F., Kastin, A. J. 2005, Direct and indirect interactions of growth hormone with the blood-brain barrier, Peptides 2005 (in press).
72. Pan, W., Zadina, J. E., Harlan, R. E., Weber, J.T., Banks, W. A., Kastin, A. J. 1997, Tumor necrosis factor α: a neuromodulator in the CNS, Neurosci. Biobehav. Rev. 21, 603-613.
73. Pan, W., Zhang, L., Liao, J., Csernus, B., Kastin, A. J. 2003, Selective increase in TNFα permeation across the blood-spinal cord barrier after SCI, J. Neuroimmunol. 134, 111-117.
74. Plotkin, S. R., Banks, W. A., Kastin, A. J. 1996, Comparison of saturable transport and extracellular pathways in the passage of interleukin-1α across the blood-brain barrier, J. Neuroimmunol. 67, 41-47.
75. Poduslo, J. F., Curran, G. L. 1996, Permeability at the blood-brain and bloodnerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF, Mol. Brain Res. 36, 280-286.
76. Poloni, M., Facchetti, D., Mai, R., Micheli, A., Agnoletti, L., Francolini, G., Mora, G., Camana, C., Mazzini, L., Bachetti, T. 2000, Circulating levels of tumor necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis, Neurosci. Lett. 287, 214.
77. Ramge, P., Kreuter, J., Lemmer, B. 1999, Circadian phase-dependent antinociceptive reaction in mice determined by the hot-plate test and the tail-flick test after intravenous injection of dalargin-loaded nanoparticles, Chronobiol. Int. 16, 767-777.
78. Rosenberg, G. A. 2002, Matrix metalloproteinases in neuroinflammation, Glia 39, 279-291.
79. Sidawy, A. N., Mitchell, M.E., Neville, R. F. 1998, Peptide growth factors and signal transduction, Semin. Vasc. Surg. 11, 149-155.
80. Stamatovic, S. M., Shakui, P., Keep, R. F., Moore, B. B., Kunkel, S. L., Van Rooijen, N., Andjelkovic, A.V. 2005, Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability, J. Cereb. Blood Flow Metab. (in press).
81. Stolphen, A. H., Guinan, E. C., Fiers, W., Pober, J.S. 1986, Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers, Am. J. Pathol. 123, 16-24.
82. Storey, H., Stewart, A., Vandenabeele, P., Luzio, J. P. 2002, The p55 tumor necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail, Biochem. J. 366, 15-22.
83. Terasaki, T., Takakuwa, S., Saheki, A., Moritani, S., Shimura, T., Tabata, S., Tsuji, A. 1992, Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells, Pharm. Res. 9, 529-534.
84. Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D.K., Lawrence, D.A. 2003, Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein, J. Clin. Invest. 112, 1533-1540.
85. Yoshihara, T., Ishigaki, S., Yamamoto, M., Liang, Y., Niwa, J., Takeuchi, H., Doyu, M., Sobue, G. 2002, Differential expression of inflammation-and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis, J. Neurochem. 80, 158-167.
86. Zhuo, M., Holtzman, D.M., Li, Y., Osaka, H., DeMaro, J., Jacquin, M., Bu, G. 2000, Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation, J. Neurosci. 20, 542-549.